Skip to NavigationSkip to content

News

AstraZeneca's Forxiga has secured approval from the European Commission for the treatment of type 1 diabetes – the first approval for the drug in...
The Advertising Standards Authority (ASA) has told British therapists to stop marketing a sham ‘cure’ for autism.
Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the...
This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on hold after a number of patient deaths...
FDA officials have called on the federal agency to halt the approval of new narcotic painkillers.
The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the billionaire controllers of...
The United States Department of Veteran Affairs (VA), the federal agency responsible for providing healthcare services to military veterans, is set...
Biogen and Eisai have announced their decision to discontinue a Phase 3 trial looking into the efficacy and safety of aducanumab in patients with...
Celgene has entered into a new three-year partnership with British artificial intelligence and drug discovery firm Exscientia to the value of at...
Johnson & Johnson has announced it is to end its practice of forced swim tests on mice, rats and other animals in the research of new drug...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches